Navigation Links
Ceelox Offers Beta Release of Ceelox ID 7 for Personal Computers
Date:5/2/2011

TAMPA, Fla., April 6, 2011 /PRNewswire/ -- Ceelox, Inc. (OTCBB: CELO) announced today the beta release of Ceelox ID 7 PC Edition which operates on computers running the Windows 7 Operating System.    

Ceelox has redesigned their authentication approach to leverage the recent capability of Windows 7.  In Windows 7, the Windows Biometric Framework (WBF) provides support for fingerprint biometric devices through a new set of components. These components improve the quality, reliability, and consistency of the user experience for customers who have fingerprint biometric devices.

Ceelox ID PC Edition which controls local access to a user's computer and provides secure login sessions for programs such as Microsoft Outlook and other applications requiring traditional user name and password.  The authentication of a user's biometric live swipe matched locally on the computer grants access only to the registered users.  This offers increased security and restricts access to a user's applications and data on their personal computer.

"By incorporating the functionality of the Windows Biometric Framework into our design, Ceelox enables the plug-in-play mentality of interoperating with any fingerprint sensor that is compatible with the WBF.  We can now offer Ceelox ID PC Edition across multiple Microsoft platforms e.g. Windows XP, Windows Vista, and Windows 7.  This is a significant step forward for the company," states Gerry Euston, CEO, Ceelox.  

About Ceelox, Inc.

Ceelox, Inc. is a developer of biometric security and encryption software solutions for financial institutions, healthcare companies, utilities, government agencies and other organizations for whom information access are key concerns.  Its security and encryption tools are easy to deploy, simple to use, cost-effective and affordable for organizations of all sizes.  

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure outlined in our Form 8-K filed with the Securities and Exchange Commission on February 12, 2010 and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

For more information visit our website at www.ceelox.com


'/>"/>
SOURCE Ceelox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Ceelox Offers Beta Release of Ceelox ID 7 for Personal Computers
2. Ceelox Provides Biometric Identity Access to Cloud Applications
3. Worm genome offers clues to evolution of parasitism
4. Advance offers revolution in food safety testing
5. Light pollution offers new global measure of coral reef health
6. Rong Li Lab offers insight into adaptive ability of cells
7. International public-private partnership offers new paradigm for medicinal chemistry
8. UC Davis discovery offers hope for treating kidney cancer
9. New paper offers key insights into how new species emerge
10. Study offers clues to beating hearing loss
11. Fighting global warming offers growth and development opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
Breaking Biology Technology: